The Role of Neuroimaging in the Diagnosis and Treatment of Depressive Disorder: A Recent Review

Title:The Role of Neuroimaging in the Diagnosis and Treatment of Depressive Disorder: A Recent Review

Volume: 24 Issue: 22

Author(s): Tianbin Song, Xiaowei Han, Lei Du, Jing Che, Jing Liu, Sumin Shi, Chao Fu, Wenwen Gao, Jie Lu*Guolin Ma*

Affiliation:

• Department of Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing,China

• Department of Radiology, China- Japan Friendship Hospital, Beijing,China

Keywords: Depressive disorder, neuroimaging, magnetic resonance imaging, cerebral blood flow, diffusion tensor imaging, positron emission tomography, single photon emission computed tomography.

Abstract: Depression is a mental disorder with serious negative health outcomes. Its main clinical manifestations are depressed mood, slow thinking, loss of interest, and lack of energy. The rising incidence of depression has a major impact on patients and their families and imposes a substantial burden on society. With the rapid development of imaging technology in recent years, researchers have studied depression from different perspectives, including molecular, functional, and structural imaging. Many studies have revealed changes in structure, function, and metabolism in various brain regions in patients with depressive disorder. In this review, we summarize relevant studies of depression, including investigations using structural magnetic resonance imaging (MRI), functional MRI (task-state fMRI and resting-state fMRI), diffusion tensor imaging (DTI), magnetic resonance spectroscopy (MRS), brain network and molecular imaging (positron emission tomography [PET] and single photon emission computed tomography [SPECT]), which have contributed to our understanding of the etiology, neuropathology, and pathogenesis of depressive disorder.

Cite this article as:

Song Tianbin , Han Xiaowei, Du Lei , Che Jing , Liu Jing , Shi Sumin , Fu Chao , Gao Wenwen , Lu Jie *, Ma Guolin *, The Role of Neuroimaging in the Diagnosis and Treatment of Depressive Disorder: A Recent Review, Current Pharmaceutical Design 2018; 24 (22) . https://dx.doi.org/10.2174/1381612824666180727111142